Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402. Bone Marrow Transplant, 53(1), 64-68. presented at the 2018 01. doi:10.1038/bmt.2017.236. (2018).
Improved Survival After Transplantation of More Donor Plasmacytoid Dendritic or Naive T Cells from Unrelated-Donor Marrow Grafts: Results From BMTCTN 0201. J Clin Oncol, 32, 2365-2372. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24982459. (2014).
Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant. presented at the 09/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25278457. (2014).
Grade III - IV Acute GvHD and Treatment-Related Mortality Are Reduced Among Recipients of Larger Numbers of Donor Naïve CD8+ T-cells and Plasmacytoid Dendritic Cell Precursors in Allogeneic BM Grafts from Unrelated Donors: Results from BMT CTN 0201. In 38th Annual EBMT (European Group for Blood and Marrow Transplantation). presented at the 01/04/2012, Geneva, Switzerland. Retrieved from http://www.congrex.ch/ebmt2012.html. (2012).